Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: A review

Israel Journal of Psychiatry and Related Sciences

Volumn 45, Issue 2, 2008, Pages 121-128

  Harel, Eiran Vadim ^a   Levkovitz, Yechiel ^a,b  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49949106247     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Kessler RC, Dernier O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005;352:2515-2523.
2. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB. The longterm natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59: 530-537.
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder, revision. Am J Psychiatry 2002; 159 :1-50.
4. Frances A, Docherty J, Kahn D. The expert consensus guideline series: Treatment of bipolar disorder. J Clin Psychiatry 1996;57:1-88.
5. Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The expert consensus guidelines for treating depression in bipolar disorder. J Clin Psychiatry 1998; 59:73-79.
6. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17:149-173.
7. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: A critical review. J Affect Dis 2005:86:1-10.
8. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-1547.
9. Tohen M, Vieta E, Calabrese J, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Efficacy of olanzapine and olanzapine fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003:60:1079-1088. [Erratum, Arch Gen Psychiatry 2004;61:176.]
10. Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989;4:313-322.
11. Himmelhoch JM, Fuchs CZ, Symons BJ. A doubleblind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982;170:628-634.
12. Mendlewicz J, Youdim MB. Antidepressant potentiation of 5-hydroxytryptophan by L-deprenyl in affective illness. J Affect Disord 1980:2:137-146.
13. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel P, Oakes R, Pitts CD. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-912.
14. Amsterdam JD, Brunswick DJ. Antidepressant monotherapy for bipolar type II major depression. Bipolar Disord 2003;5:388-395.
15. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004;161:163-165.
16. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007:356:1711-1722.
17. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163:232-239.
18. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A doubleblind study. Arch Gen Psychiatry 1981;38:902-907.
19. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559.
20. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: Contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145:179-184.
21. Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J. The impact of antidepressant discontinuation versus antidepressant continuation on 1 - year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001;62:612-616.
22. Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Waiden J, Leverich G, Denicoff K, Luckenbaugh D, Post R. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003;160: 1252-1262.
23. Belmaker RH. Treatment of bipolar depression. N Engl J Med 2007:356:1771-1773.